Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-27

Clinical Trial Update: A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing SB206 gel to vehicle in Molluscum Contagiosum completed with posted results in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SB206

Snippet

Sponsor: Novan, Inc. | Conditions: Molluscum Contagiosum | Phase 3 | Status: COMPLETED | Results posted: 2022-12-27